Key result
This review clarifies the existing literature regarding the clinical characteristics and pathophysiology of the newly defined subgroup of heart failure with mildly reduced ejection fraction.
Answers are grounded in this paper and cite their sources.
This review clarifies the clinical characteristics and pathophysiology of the newly defined HFmrEF patient subgroup.
Since the publication of European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure (HF) in 2016, a new class of HF has been defined, namely HF with mildly reduced ejection fraction (HFmrEF). Although the name was new, there had long been awareness of the existence of a grey area between the two established classes of HF: HF with reduced ejection fraction and HF with preserved ejection fraction. Patients between these two classes were previously either excluded from HF studies or were included in the other groups. With the definition of this new group of patients, a door has opened for researchers to further explore their characteristics, treatment and outcomes. In this article we aim to clarify the existing literature on the clinical characteristics and pathophysiology of this newly-defined group of patients.
No takes yet. Share an insight, caveat, or question.
Nadar et al. (2018) conducted a review in Heart Failure with mildly reduced ejection fraction (HFmrEF). This review clarifies the existing literature regarding the clinical characteristics and pathophysiology of the newly defined subgroup of heart failure with mildly reduced ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: